Applied DNA Corp (APDN) - Earnings per share increase in current year
How does expansion into synthetic biology and logistics security segments impact the profitability of Applied DNA Sciences (APDN)? The YoY net income per share change coefficient on the precise GURU.Markets chart confirms a trend where the 0.00 level indicates the parameter's status. The robotization of molecular tag synthesis minimizes oversight, while delegating IT infrastructure to the cloud while maintaining internal production control eliminates operational risks.
Comprehensive metric breakdowns and analytics for Applied DNA Sciences, Inc. (APDN)
- stock quotes and analyst forecast:
- market capitalization indicators:
- business book valuation details:
- debt burden and liquidity indicators:
Total Debt to Capital Applied DNA Sciences|APDN - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Applied DNA Sciences Inc|APDN - Company Debts|Debts to Net Assets Applied DNA Sciences|APDN - Company Long-Term Debts|Company Current Liabilities Applied DNA Sciences|Interim Coverage Ratio adnas.com
- earnings and market ratios statistics:
APDN - Net Profit|Expected Net Profit Applied DNA Sciences|APDN - Price to Earnings Ratio|Price to Future Earnings Ratio Applied DNA Sciences|APDN - PEG Multiple|Enterprise Value to EBITDA Ratio Applied DNA Sciences|APDN - Operating profit EBITDA|Net earnings per one share for the last twelve months Applied DNA Sciences|APDN - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months adnas.com|APDN - Earnings growth in current year|Earnings growth forecast for next year Applied DNA Sciences
- revenue and sales proceeds data:
Basic company analysis:APDN - Applied DNA
This indicator measures the year-over-year dynamics of earnings per share, capturing the rate of change in the business's net profitability. Professional investors track annual EPS growth to assess operational resilience and identify a company's maturity phase. For Applied DNA Sciences (APDN), this metric reflects the monetization efficiency of synthetic DNA and molecular verification systems amid market volatility.
Direct competitors
Tempus AI, Inc (TEM) - Earnings growth in current year|Earnings per share growth in current year Qiagen|IONS: Earnings per share increase in current year|Net earnings per share growth this year RGEN (Repligen)|Expected net earnings per share growth this year Avidity Biosciences Inc|Earnings growth in current year CRSP (crisprtx.com)|WGS: Earnings per share growth this year|RARE: Net earnings per share growth this year|Earnings per share trend in current year BEAM|Sarepta (SRPT) - Earnings per share growth in current year|TWST - Expected net earnings per share growth this year|Earnings per share growth in current year 10x Genomics, Inc.|NTLA: Earnings per share increase in current year|Net earnings per share growth this year STOK (Stoke Corp)|Expected net earnings per share growth this year biolifesolutions.com|Earnings growth in current year WVE (Wave Life Sciences Ltd)|Expected net earnings per share growth this year Maze Therapeutics (MAZE)|SION: Net earnings per share growth this year|Expected net earnings per share growth this year Prime Medicine Bio PRME|TSHA: Earnings growth in current year|Earnings per share growth this year QURE|Net earnings per share growth this year MGTX|Earnings per share growth this year RGNX (REGENXBIO)|Earnings growth in current year SLDB|OCGN - Earnings per share growth rate in current year|Earnings per share growth in current year Pacific Biosciences of California PACB|BNTC: Earnings per share growth this year|DSGN - Earnings per share growth in current year|RCKT: Earnings per share growth in current year|FDMT - Net earnings per one share growth for the current year|Earnings per share growth rate in current year Lexeo Therapeutics Inc. (LXEO)|Earnings per share growth in current year Korro Bio Inc.|Editas Medicine (EDIT) - Expected net earnings per share growth this year|Earnings per share growth in current year Silence Therapeutics Inc. (SLN)|PRQR: Earnings per share trend in current year|Earnings growth in current year CDXS (codexis.com)|SGMO: Earnings per share growth this year|NAUT: Net earnings per share growth this year|Earnings per share growth rate in current year metagenomi.co|Precision BioSciences, Inc. (DTIL) - Earnings per share growth in current year|Earnings per share growth rate in current year Generation Bio Corp (GBIO)|Net earnings per share growth this year BOLD|exicuretx.com (XCUR) - Expected net earnings per share growth this year|Net earnings per share growth this year IMNN (Celsion Corporation)|PHIO (Phio Pharmaceuticals Corp.) - Earnings per share increase in current year|Earnings growth in current year MBIO (Mustang Bio Corp)|Net earnings per one share growth for the current year RNAZ (TransCode Therapeutics)|BNGO - Earnings per share growth in current year|Earnings per share increase in current year BLUE (Bluebird Bio)|ImmunoPrecise (IPA) - Earnings per share growth in current year|OMGA: Net earnings per one share growth for the current year|Earnings per share growth in current year Singular Genomics Systems, Inc.|Earnings growth in current year Regulus Therapeutics, Inc.|Net earnings per share growth this year SYRS (Syros)|TBIO - Earnings per share growth rate in current year|Earnings per share growth in current year TRACON Pharmaceuticals, Inc. TCON|Unity Biotechnology (UBX) - Earnings per share growth rate in current year
